To ascertain the anti-HCC activity of intratumoral CD8+CD44+CD62L− T cells, expression of cytotoxic mediators in intratumoral CD8+CD44−CD62L+ and CD8+CD44+CD62L− T cells were assessed through intracellular staining. The gene discussed is CD44; the disease is hepatocellular carcinoma.